Helixconstraints and amino acid substitution in GLP-1 increase cAMP and insulin secretion but not beta-arrestin 2 signaling.

Saved in:
Bibliographic Details
Title: Helixconstraints and amino acid substitution in GLP-1 increase cAMP and insulin secretion but not beta-arrestin 2 signaling.
Authors: Plisson F; Division of Chemistry and Structural Biology, Institute for Molecular Bioscience, The University of Queensland, St. Lucia, QLD 4072, Australia., Hill TA; Division of Chemistry and Structural Biology, Institute for Molecular Bioscience, The University of Queensland, St. Lucia, QLD 4072, Australia. Electronic address: t.hill@imb.uq.edu.au., Mitchell JM; Division of Chemistry and Structural Biology, Institute for Molecular Bioscience, The University of Queensland, St. Lucia, QLD 4072, Australia., Hoang HN; Division of Chemistry and Structural Biology, Institute for Molecular Bioscience, The University of Queensland, St. Lucia, QLD 4072, Australia., de Araujo AD; Division of Chemistry and Structural Biology, Institute for Molecular Bioscience, The University of Queensland, St. Lucia, QLD 4072, Australia., Xu W; Division of Chemistry and Structural Biology, Institute for Molecular Bioscience, The University of Queensland, St. Lucia, QLD 4072, Australia., Cotterell A; Division of Chemistry and Structural Biology, Institute for Molecular Bioscience, The University of Queensland, St. Lucia, QLD 4072, Australia., Edmonds DJ; Worldwide Medicinal Chemistry, Cardiovascular, Metabolic & Endocrine Diseases Research Unit, Pfizer Inc., Cambridge, MA 02140, United States., Stanton RV; Worldwide Medicinal Chemistry, Cardiovascular, Metabolic & Endocrine Diseases Research Unit, Pfizer Inc., Cambridge, MA 02140, United States., Derksen DR; Pharmacokinetics, Dynamics and Metabolism, Pfizer Inc., Groton, CT 06340, United States., Loria PM; Pharmacokinetics, Dynamics and Metabolism, Pfizer Inc., Groton, CT 06340, United States., Griffith DA; Worldwide Medicinal Chemistry, Cardiovascular, Metabolic & Endocrine Diseases Research Unit, Pfizer Inc., Cambridge, MA 02140, United States., Price DA; Worldwide Medicinal Chemistry, Cardiovascular, Metabolic & Endocrine Diseases Research Unit, Pfizer Inc., Cambridge, MA 02140, United States., Liras S; Worldwide Medicinal Chemistry, Cardiovascular, Metabolic & Endocrine Diseases Research Unit, Pfizer Inc., Cambridge, MA 02140, United States., Fairlie DP; Division of Chemistry and Structural Biology, Institute for Molecular Bioscience, The University of Queensland, St. Lucia, QLD 4072, Australia. Electronic address: d.fairlie@imb.uq.edu.au.
Source: European journal of medicinal chemistry [Eur J Med Chem] 2017 Feb 15; Vol. 127, pp. 703-714. Date of Electronic Publication: 2016 Oct 21.
Publication Type: Journal Article
Journal Info: Publisher: Editions Scientifiques Elsevier Country of Publication: France NLM ID: 0420510 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1768-3254 (Electronic) Linking ISSN: 02235234 NLM ISO Abbreviation: Eur J Med Chem Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 27823886
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Helixconstraints and amino acid substitution in GLP-1 increase cAMP and insulin secretion but not beta-arrestin 2 signaling.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Plisson+F%22">Plisson F</searchLink>; Division of Chemistry and Structural Biology, Institute for Molecular Bioscience, The University of Queensland, St. Lucia, QLD 4072, Australia.<br /><searchLink fieldCode="AU" term="%22Hill+TA%22">Hill TA</searchLink>; Division of Chemistry and Structural Biology, Institute for Molecular Bioscience, The University of Queensland, St. Lucia, QLD 4072, Australia. Electronic address: t.hill@imb.uq.edu.au.<br /><searchLink fieldCode="AU" term="%22Mitchell+JM%22">Mitchell JM</searchLink>; Division of Chemistry and Structural Biology, Institute for Molecular Bioscience, The University of Queensland, St. Lucia, QLD 4072, Australia.<br /><searchLink fieldCode="AU" term="%22Hoang+HN%22">Hoang HN</searchLink>; Division of Chemistry and Structural Biology, Institute for Molecular Bioscience, The University of Queensland, St. Lucia, QLD 4072, Australia.<br /><searchLink fieldCode="AU" term="%22de+Araujo+AD%22">de Araujo AD</searchLink>; Division of Chemistry and Structural Biology, Institute for Molecular Bioscience, The University of Queensland, St. Lucia, QLD 4072, Australia.<br /><searchLink fieldCode="AU" term="%22Xu+W%22">Xu W</searchLink>; Division of Chemistry and Structural Biology, Institute for Molecular Bioscience, The University of Queensland, St. Lucia, QLD 4072, Australia.<br /><searchLink fieldCode="AU" term="%22Cotterell+A%22">Cotterell A</searchLink>; Division of Chemistry and Structural Biology, Institute for Molecular Bioscience, The University of Queensland, St. Lucia, QLD 4072, Australia.<br /><searchLink fieldCode="AU" term="%22Edmonds+DJ%22">Edmonds DJ</searchLink>; Worldwide Medicinal Chemistry, Cardiovascular, Metabolic & Endocrine Diseases Research Unit, Pfizer Inc., Cambridge, MA 02140, United States.<br /><searchLink fieldCode="AU" term="%22Stanton+RV%22">Stanton RV</searchLink>; Worldwide Medicinal Chemistry, Cardiovascular, Metabolic & Endocrine Diseases Research Unit, Pfizer Inc., Cambridge, MA 02140, United States.<br /><searchLink fieldCode="AU" term="%22Derksen+DR%22">Derksen DR</searchLink>; Pharmacokinetics, Dynamics and Metabolism, Pfizer Inc., Groton, CT 06340, United States.<br /><searchLink fieldCode="AU" term="%22Loria+PM%22">Loria PM</searchLink>; Pharmacokinetics, Dynamics and Metabolism, Pfizer Inc., Groton, CT 06340, United States.<br /><searchLink fieldCode="AU" term="%22Griffith+DA%22">Griffith DA</searchLink>; Worldwide Medicinal Chemistry, Cardiovascular, Metabolic & Endocrine Diseases Research Unit, Pfizer Inc., Cambridge, MA 02140, United States.<br /><searchLink fieldCode="AU" term="%22Price+DA%22">Price DA</searchLink>; Worldwide Medicinal Chemistry, Cardiovascular, Metabolic & Endocrine Diseases Research Unit, Pfizer Inc., Cambridge, MA 02140, United States.<br /><searchLink fieldCode="AU" term="%22Liras+S%22">Liras S</searchLink>; Worldwide Medicinal Chemistry, Cardiovascular, Metabolic & Endocrine Diseases Research Unit, Pfizer Inc., Cambridge, MA 02140, United States.<br /><searchLink fieldCode="AU" term="%22Fairlie+DP%22">Fairlie DP</searchLink>; Division of Chemistry and Structural Biology, Institute for Molecular Bioscience, The University of Queensland, St. Lucia, QLD 4072, Australia. Electronic address: d.fairlie@imb.uq.edu.au.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220420510%22">European journal of medicinal chemistry</searchLink> [Eur J Med Chem] 2017 Feb 15; Vol. 127, pp. 703-714. <i>Date of Electronic Publication: </i>2016 Oct 21.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Editions+Scientifiques+Elsevier%22">Editions Scientifiques Elsevier </searchLink><i>Country of Publication: </i>France <i>NLM ID: </i>0420510 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1768-3254 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2202235234%22">02235234 </searchLink><i>NLM ISO Abbreviation: </i>Eur J Med Chem <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=27823886
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.ejmech.2016.10.044
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 703
    Titles:
      – TitleFull: Helixconstraints and amino acid substitution in GLP-1 increase cAMP and insulin secretion but not beta-arrestin 2 signaling.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Plisson F
      – PersonEntity:
          Name:
            NameFull: Hill TA
      – PersonEntity:
          Name:
            NameFull: Mitchell JM
      – PersonEntity:
          Name:
            NameFull: Hoang HN
      – PersonEntity:
          Name:
            NameFull: de Araujo AD
      – PersonEntity:
          Name:
            NameFull: Xu W
      – PersonEntity:
          Name:
            NameFull: Cotterell A
      – PersonEntity:
          Name:
            NameFull: Edmonds DJ
      – PersonEntity:
          Name:
            NameFull: Stanton RV
      – PersonEntity:
          Name:
            NameFull: Derksen DR
      – PersonEntity:
          Name:
            NameFull: Loria PM
      – PersonEntity:
          Name:
            NameFull: Griffith DA
      – PersonEntity:
          Name:
            NameFull: Price DA
      – PersonEntity:
          Name:
            NameFull: Liras S
      – PersonEntity:
          Name:
            NameFull: Fairlie DP
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 15
              M: 02
              Text: 2017 Feb 15
              Type: published
              Y: 2017
          Identifiers:
            – Type: issn-electronic
              Value: 1768-3254
          Numbering:
            – Type: volume
              Value: 127
          Titles:
            – TitleFull: European journal of medicinal chemistry
              Type: main
ResultId 1